Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

German investor Angermayer to launch biotech SPAC in the U.S. -sources

02/17/2021 | 12:31pm EDT

BERLIN, Feb 17 (Reuters) - German investor Christian Angermayer is planning to list a blank-cheque company in New York, embracing a trend that has seen a swathe of entrepreneurs tapping into investor interest in new offerings, two people close to the matter said.

His Frontier Acquisition Corp., a special purpose acquisition company (SPAC), is planning to sell shares worth $200 million and will have a biotech focus, the sources said, adding that an official filing could take place in the coming days with a listing as early as March.

The SPAC is being sponsored by Angermayer's family fund Apeiron Investment Group as well as by venture capital firm Falcon Edge, known for investments in companies like Uber , Delivery Hero, Alibaba and Swipe, they added.

Angermayer's Apeiron declined to comment while Falcon Edge was not immediately available for comment.

SPACs, so-called blank cheque companies, raise funds in an initial public offering with the aim of buying a private firm. The United States has seen a boom in SPAC listings, while there have been relatively few in Europe.

German venture capitalist Klaus Hommels launched a blank cheque company in Frankfurt on Wednesday through his firm Lakestar, while former UniCredit boss Jean-Pierre Mustier earlier this week teamed up with French tycoon Bernard Arnault to launch a SPAC in Amsterdam.

Like Angermayer, other entrepreneurs have chosen to seek a U.S. listing, including the SPAC of former Credit Suisse CEO Tidjane Thiam and Egyptian billionaire Nassef Onsi Sawiris.

Oliver Samwer, the founder of German tech investment company Rocket Internet, and meal kit delivery company Hellofresh founder and Chief Executive Dominik Richter are also planning to list SPACs in New York.

Angermayer is a serial entrepreneur, backing about 30 biotech companies including Atai Life Sciences, which is developing anti-depression drugs from so-called magic mushrooms.

Angermayer was also an investor in immunotherapies firm Sensei Biotherapeutics, mental health care company Compass Pathways and artificial intelligence-powered drug discovery platform Abcellera, all of which listed in the United States in recent months.

Frontier Acquisition Corp., which will focus on the intersection of data and life sciences, is planning to sell 20 million shares at $10 each, with an over-allotment option of 3 million additional shares, the sources said.

Credit Suisse is organising the IPO, the sources said, adding that David Sinclair and Peter Attia, founders in the biotech and tech space will serve as co-chairmen, while Angermayer will serve as CEO and Falcon Edge founder Ryan Khoury as President. Credit Suisse declined to comment. (Editing by Emelia Sithole-Matarise)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ALIBABA GROUP HOLDING LIMITED -0.17% 238.69 Delayed Quote.2.56%
COMPASS PATHWAYS PLC 0.94% 34.35 Delayed Quote.-28.57%
CREDIT SUISSE GROUP AG 1.00% 9.9 Delayed Quote.-13.16%
DELIVERY HERO SE 1.14% 128.45 Delayed Quote.1.14%
HELLOFRESH SE 3.28% 73.64 Delayed Quote.16.52%
UNICREDIT S.P.A. 1.07% 8.519 Delayed Quote.11.39%
Latest news "Economy & Forex"
03:58aBitcoin falls 7.7% to $55,408
RE
03:18aTaiwan says it has never sought to use exchange rate for trade advantage
RE
03:17aChina revised march trade balance $+13.8 bln (prelim $+13.8 bln) €€
RE
03:17aChina revised march dollar-denominated imports +38.1% y/y (prelim +38.1% y/y)
RE
03:17aChina revised march dollar-denominated exports +30.6% y/y (prelim +30.6% y/y)
RE
03:02aChina administered total of 189.81 mln doses of COVID-19 vaccines as of April 17
RE
03:02aChina administered total of 189.81 million doses of covid-19 vaccines as of april 17 - health authority
RE
02:57aExclusive-Italy risks missing Recovery Plan deadline due to EU concerns, sources say
RE
01:53aSaudi and Iranian officials held talks to patch up relations - FT
RE
12:58aSaudi and Iranian officials held talks to patch up relations - FT
RE
Latest news "Economy & Forex"